Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.51 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL800090 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL5182292 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL119475 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL29908079 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL29682425 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL29401101 | 1.00 | MDM4 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL27435787 | 0.94 | MDM2 (0.56) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL29694496 | 0.93 | PTPN1 (0.58) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL30929979 | 0.92 | TLR2 (0.49) | MDM4TP53TLR2MDM2KMT2A | |
| SCHEMBL30255589 | 0.92 | TLR2 (0.49) | MDM4TP53TLR2MDM2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075733-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122031713-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | 乐普生物科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4659764-A1 | LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF | Lepu Biopharma Co., Ltd. (CN) | 2025-12-10 | — | — | EP | claimed |
| CN-119930788-A | Preparation method of Retatrutide | 四川吉晟生物医药有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119823233-A | Synthesis method of Ruitalutide and Ruitalutide | 杭州思诺达医药科技有限责任公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119708197-A | Ruitalu Process for producing peptide | 深圳翰宇药业股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2024160176-A1 | LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF | 上海美雅珂生物技术有限责任公司 | 2024-08-08 | — | — | WO | claimed |
| CN-118005767-A | Method for preparing Tirzepatide by combining solid and liquid | 柏佳薇(深圳)生物科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117890507-A | Liquid chromatography detection method for protecting amino acid impurities | 江苏诺泰澳赛诺生物制药股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117866074-A | Method for preparing teicoplanin by solid-liquid phase combination | 瑞博(苏州)制药有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-111514303-B | Triple-negative breast cancer targeted drug carrier and preparation and application thereof | 江苏省人民医院（南京医科大学第一附属医院） | 2022-07-26 | — | — | CN | claimed |
| CN-114736271-A | Synthesis method of Tirzepatide | 杭州诺泰澳赛诺医药技术开发有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114685613-A | Preparation method of terlipressin impurity Q | 深圳翰宇药业股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114621317-A | Activatable multi-modal molecular probe for early diagnosis of prostate cancer and in-vivo longitudinal quantitative research, and preparation method and application thereof | 苏州大学 | 2022-06-14 | — | — | CN | claimed |
| CN-114591398-A | Polypeptide-modified fluorescein derivative and preparation method and application thereof | 山西大学 | 2022-06-07 | — | — | CN | claimed |
| CN-114539358-A | Polypeptide, preparation method and application | 中国科学院大连化学物理研究所 | 2022-05-27 | — | — | CN | claimed |
| CN-112175067-B | Preparation method of teduglutide | 深圳市星银医药有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113135988-B | Preparation method of thymosin beta 4 | 润辉生物技术（威海）有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113121673-B | Method for preparing elcatonin by solid-liquid combination method | 润辉生物技术（威海）有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-113956332-A | Near-infrared probe with high affinity for early gastric cancer and preparation method thereof | 中国人民解放军空军军医大学 | 2022-01-21 | — | — | CN | claimed |